[ Price : $8.95]
FDA faces Increased scrutiny of its newly established Commissioners National Priority Review voucher program, which is intended to...[ Price : $8.95]
House and Senate Democratic health leaders ask AstraZeneca, Lilly, Novo Nordisk, and Pfizer for details about the drug pricing dea...[ Price : $8.95]
FDA cites SCA Pharmaceuticals for multiple deficiencies in sterile drug manufacturing practices following a 10-day inspection of t...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion says a TV spot for Karuna Therapeutics Cobenfy is false or misleading in its descri...[ Price : $8.95]
FDA releases the form FDA-483 with five observations from a recent inspection of the UBI Pharma drug manufacturing facility in Hsi...[ Price : $8.95]
A new study shows that Eli Lillys investigational oral obesity drug helped patients largely maintain weight loss after transitioni...[ Price : $8.95]
Novo Nordisk says it expects FDA to review in 2026 the companys NDA for CagriSema, an injectable once-weekly weight loss treatment...[ Price : $8.95]
FDA begins enforcement actions against companies illegally marketing breast binders to children, placing the agencys role at the c...